A small molecule induces integrin β4 nuclear translocation and apoptosis selectively in cancer cells with high

Shu Yan Liu1, Di Ge2,3, Li Na Chen1

  • 1Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University, Jinan 250100, China.

Oncotarget
|February 27, 2016
PubMed

Insights

A novel small molecule, SEC, selectively induces cancer cell death in tumors with high integrin β4 (ITGB4) expression. This targeted approach involves ITGB4 nuclear translocation, activating pro-apoptosis genes for potential new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Elevated integrin β4 (ITGB4) expression correlates with advanced carcinoma progression.
  • Targeted therapies for ITGB4-high cancer cells remain underdeveloped.

Purpose of the Study:

  • To identify and characterize a small molecule that selectively targets cancer cells with high ITGB4 expression.
  • To elucidate the molecular mechanisms underlying the selective anti-cancer effects of the identified molecule.

Main Methods:

  • Screening of small molecules for selective cytotoxicity against ITGB4-expressing cancer cells.
  • Investigating the role of ITGB4 nuclear translocation and its downstream effects.
  • Assessing the efficacy of the small molecule in an avian embryo xenograft tumor model.

Main Results:

  • A chiral small molecule, SEC, was identified that selectively induces apoptosis in cancer cells with high ITGB4 levels.
  • SEC promotes ITGB4 nuclear translocation, leading to ATF3 activation and upregulation of pro-apoptotic genes.
  • SEC enhances annexin A7 (ANXA7) binding to ITGB4, increasing ANXA7 GTPase activity and ITGB4 phosphorylation at Y1494.
  • SEC demonstrated significant inhibition of xenograft tumor growth in vivo.

Conclusions:

  • SEC represents a novel therapeutic agent with selective pro-apoptotic activity against ITGB4-high cancers.
  • The mechanism involves SEC-mediated ITGB4-ANXA7 interaction, nuclear trafficking, and subsequent activation of apoptotic pathways.
  • SEC shows promise for both in vitro and in vivo cancer treatment strategies targeting ITGB4 expression.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
6.0K